Ontology highlight
ABSTRACT: Background
Liposomal bupivacaine is claimed by the manufacturer to provide analgesia for up to 72 h postoperatively.Objectives
To compare the postoperative analgesic efficacy of liposomal bupivacaine versus long-acting local anaesthetics for peripheral nerve or field blocks.Design
A systematic review and meta-analysis with trial sequential analysis.Data sources
MEDLINE, Embase and Web of Science, among others, up to June 2022.Eligibility criteria
We retrieved randomised controlled trials comparing liposomal bupivacaine versus bupivacaine, levobupivacaine or ropivacaine for peripheral nerve and field blocks after all types of surgery. Our primary endpoint was rest pain score (analogue scale 0 to 10) at 24 h. Secondary endpoints included rest pain scor
SUBMITTER: Nguyen A
PROVIDER: S-EPMC10860892 | biostudies-literature | 2023 Sep
REPOSITORIES: biostudies-literature